# FibroBiologics, Inc.: Form 8-K, filed Feb 23, 2026

- Company: [FibroBiologics, Inc.](/companies/fblg.md) (CIK 1958777)
- Form: 8-K
- Filed: 2026-02-23
- Accepted by EDGAR: Feb 23, 2026, 21:18 ET
- Period: 2026-02-20
- Accession: 0001193125-26-064040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526064040/fblg-20260220.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1958777/000119312526064040/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1958777/000119312526064040/fblg-20260220.htm

Filed Feb 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-064040. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.
